KRISTIN WEBER: Open Payments
NPI 1487710067 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,288 in 30 payments from 18 companies in 2025. Trend: 2023 $13,588 · 2024 $2,965 · 2025 $4,288
Consulting: $3,776Food & beverage: $487Education: $25
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $2,183 |
| BioCryst Pharmaceuticals, Inc. | 1 | $1,608 |
| Cycle Pharmaceuticals Inc | 3 | $87 |
| BioCryst US Sales Co., LLC | 4 | $48 |
| LEO Pharma Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $32 |
| ABBVIE INC. | 2 | $30 |
Products named: CUVITRU, ORLADEYO, Sajazir, TEZSPIRE, NUCALA, Symbravo, Hillrom - Vest System Model 105 Home Care, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MN — which companies pay providers there.
